BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16700047)

  • 1. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.
    Breslow NE; Beckwith JB; Perlman EJ; Reeve AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):260-7. PubMed ID: 16700047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors.
    Fukuzawa R; Reeve AE
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):589-94. PubMed ID: 17805030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.
    Beckwith JB
    Am J Med Genet; 1998 Oct; 79(4):268-73. PubMed ID: 9781906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
    Vujanić GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.
    Beckwith JB; Kiviat NB; Bonadio JF
    Pediatr Pathol; 1990; 10(1-2):1-36. PubMed ID: 2156243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess.
    Leisenring WM; Breslow NE; Evans IE; Beckwith JB; Coppes MJ; Grundy P
    Cancer Res; 1994 Sep; 54(17):4680-3. PubMed ID: 8062264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Wilms' tumor: a descriptive study.
    Breslow NE; Olson J; Moksness J; Beckwith JB; Grundy P
    Med Pediatr Oncol; 1996 Nov; 27(5):398-403. PubMed ID: 8827065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study.
    Breslow N; Sharples K; Beckwith JB; Takashima J; Kelalis PP; Green DM; D'Angio GJ
    Cancer; 1991 Dec; 68(11):2345-53. PubMed ID: 1657352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
    Fukuzawa R; Heathcott RW; More HE; Reeve AE
    J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic rests in Wilms tumor patients with the Drash syndrome.
    Heppe RK; Koyle MA; Beckwith JB
    J Urol; 1991 Jun; 145(6):1225-8. PubMed ID: 1851891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precursor lesions of Wilms tumor: clinical and biological implications.
    Beckwith JB
    Med Pediatr Oncol; 1993; 21(3):158-68. PubMed ID: 8383276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms tumor: an update.
    Al-Hussain T; Ali A; Akhtar M
    Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group.
    Breslow NE; Norris R; Norkool PA; Kang T; Beckwith JB; Perlman EJ; Ritchey ML; Green DM; Nichols KE;
    J Clin Oncol; 2003 Dec; 21(24):4579-85. PubMed ID: 14673045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study.
    Mishra K; Mathur M; Logani KB; Kakkar N; Krishna A
    Cancer; 1998 Nov; 83(10):2228-32. PubMed ID: 9827730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of Wilms' tumor.
    Sharpe CR; Franco EL
    Epidemiol Rev; 1995; 17(2):415-32. PubMed ID: 8654519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.
    Sandberg JK; Chi YY; Smith EA; Servaes S; Hoffer FA; Mullen EA; Perlman EJ; Tornwall B; Ehrlich PF; Geller JI; Grundy PE; Fernandez CV; Dome JS; Khanna G
    AJR Am J Roentgenol; 2020 May; 214(5):987-994. PubMed ID: 32160052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.